SCS Capital Management LLC
Source: SEC Form 13F · as of Mar 2026SCS Capital Management LLC holds 26 biotech & pharma companies tracked by BioSniper, totaling $156.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
26
Total value held
$156.6M
| Company | Shares | Value |
|---|---|---|
| ALNYALNYLAM PHARMACEUTICALS, INC. | 149,547 | $49.5M |
| JNJJOHNSON & JOHNSON | 151,322 | $37.0M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 612,850 | $20.7M |
| AZNASTRAZENECA PLC | 87,349 | $17.0M |
| LLYELI LILLY & Co | 11,507 | $10.6M |
| DNLIDenali Therapeutics Inc. | 197,998 | $3.8M |
| ABBVAbbVie Inc. | 13,582 | $3.0M |
| MRKMerck & Co., Inc. | 22,613 | $2.7M |
| ABTABBOTT LABORATORIES | 18,414 | $1.9M |
| AMGNAMGEN INC | 4,448 | $1.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,309 | $1.2M |
| BCAXBicara Therapeutics Inc. | 53,430 | $1.1M |
| GILDGILEAD SCIENCES, INC. | 6,563 | $915K |
| PMPhilip Morris International Inc | 5,189 | $859K |
| PFEPFIZER INC | 29,591 | $831K |
| DNTHDianthus Therapeutics, Inc. /DE/ | 9,375 | $787K |
| ANNXAnnexon, Inc. | 99,000 | $548K |
| FHTXFoghorn Therapeutics Inc. | 106,980 | $511K |
| ANROAlto Neuroscience, Inc. | 16,840 | $379K |
| RVMDREVOLUTION MEDICINES, INC. | 3,867 | $376K |
| REGNREGENERON PHARMACEUTICALS, INC. | 471 | $364K |
| BMYBRISTOL MYERS SQUIBB CO | 4,855 | $294K |
| NVONovo Nordisk A/S | 7,505 | $284K |
| SANASana Biotechnology, Inc. | 81,250 | $234K |
| VIRVir Biotechnology, Inc. | 24,200 | $217K |
| EDITEditas Medicine, Inc. | 35,000 | $86K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.